NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $69.12M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.23M
Average 0.18M
NRXS Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
NeurAxis, Inc.AMEX: NRXS
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 2123.6% from a year ago
Total equity stood at $5.75M at the end of Q1 FY2026, up 2123.6% from a year earlier and up 69.1% from the prior quarter.
Context
- Total equity amounted to 65.7% of total assets at the end of Q1 FY2026, up 57.2 pp from a year earlier.
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +2123.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 3.4M USD
- Year-over-year change
- +64.4%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.4M | +64.4% |
| FY2024 | 2024-12-31 | 2.07M | +247.4% |
| FY2023 | 2023-12-31 | (1.4M) | +74.8% |
| FY2022 | 2022-12-31 | (5.57M) | -575.0% |
| FY2021 | 2021-12-31 | (825.66K) | — |
Total Equity vs competitors
How NRXS compares with its peers on the latest reported figures
- NRXS's Mar 2026 total equity of $5.75M is the 3rd highest of the 4 companies compared; the peer median is $50.28M.
- Its year-over-year change of +2123.6% is the 2nd highest of 4, against a peer median of -7.0%.
- Total equity amounts to 65.7% of total assets for NRXS, versus a peer median of 92.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $1.93B | +8102.8% | +224.1% | 83.2% | |
| Mar 2026 | $50.28M | -7.0% | -30.0% | 92.3% | |
NRXSNeurAxis, Inc. | Mar 2026 | $5.75M | +2123.6% | — | 65.7% |
| Jun 2026 | -$201.56B | -627630.4% | — | 212.0% | |
| Peer median (excluding NRXS) | $50.28M | -7.0% | +97.0% | 92.3% | |
Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 320.86K | 253.7K | 78.56K | 3.7M | 4.97M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 115.3K | 174.4K | 73.17K | 244.62K | 195.7K |
| Inventory | 39.18K | 48.13K | 21.22K | 44.33K | 257.13K |
| Other Current Assets | 0 | 726 | 69.66K | 280.37K | 70.59K |
| Total Current Assets | 491.01K | 476.96K | 242.61K | 4.27M | 5.73M |
| Property, Plant & Equipment (Net) | 245.52K | 189.39K | 158.82K | 374.64K | 337.13K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 23.96K | 77.56K | 108.07K | 96.59K | 274.78K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 736.74K | 0 | 20.16K | 58.94K |
| Total Non-current Assets | 269.47K | 1M | 266.89K | 491.39K | 670.85K |
| Total Assets | 760.48K | 1.48M | 509.5K | 4.76M | 6.4M |
| Account Payables | 483.79K | 1.59M | 1.2M | 596.95K | 139.37K |
| Short-term Debt | 250.41K | 489.23K | 148.06K | 154.15K | 148.29K |
| Tax Payables | 563 | 777 | 0 | 0 | 0 |
| Deferred Revenue | 69.34K | 59.17K | 74.95K | 32.53K | 28.66K |
| Other Current Liabilities | 43.84K | 4.51M | 341.7K | 1.27M | 2.07M |
| Total Current Liabilities | 1.42M | 6.98M | 1.89M | 2.43M | 2.79M |
| Long-term Debt | 51.69K | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 10K |
| Total Non-current Liabilities | 161.29K | 76.2K | 27.07K | 256.5K | 212.57K |
| Total Liabilities | 1.59M | 7.05M | 1.91M | 2.69M | 3M |
| Common Stock | 2.55K | 1.96K | 6.51K | 6.99K | 10.65K |
| Retained Earnings | (29.15M) | (33.93M) | (48.56M) | (56.8M) | (64.6M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (825.66K) | (5.57M) | (1.4M) | 2.07M | 3.4M |
| Total Debt | 439.28K | 598.82K | 224.26K | 473.41K | 416.61K |
| Net Debt | 118.42K | 345.12K | 145.7K | (3.22M) | (4.55M) |
NeurAxis, Inc.
AMEX:NRXS
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.